Developer docs
API playgroundTry for free, no card

Search company profiles

Reine Lifescience

Full company profile

uuid00vnofc

Namestring
Reine Lifescience
Legal namestring
Reine Lifescience
Company typeenum
Private
Founded yearint
1993
Descriptiontext

Reine Lifescience is a privately held Indian active pharmaceutical ingredient (API) manufacturer headquartered in Ankleshwar, Gujarat, that also operates as a contract development and manufacturing organization (CDMO) for global pharmaceutical clients. Founded in 1993 as Reine Chemicals Pvt. Ltd. and rebranded in 2014-2015 to reflect its pivot into regulated pharmaceutical APIs, the company runs cGMP-compliant manufacturing facilities spanning more than 20,000 square meters with 200+ KL of reactor capacity and approximately 2,000 MT/year of API production output. Its commercial portfolio covers roughly 27-29 APIs across therapeutic categories such as cardiovascular, anti-hypertensive, anti-diabetic, anti-epilepsy, anticoagulant, neuropathic pain, anti-allergic, anti-asthmatic, and iron chelation, manufactured to IP, BP, EP, and USP pharmacopeial standards, with five additional APIs in development.

The company holds a layered regulatory stack — WHO-GMP, CEP/EDQM, MFDS Korea, ANVISA (post-2026 inspection), and ISO 9001/14001/45001 — and exports to 45+ countries across South Asia, Asia Pacific, Europe, and global markets. Its technical capabilities rest on advanced organic synthesis (cyclization, condensations, hydrogenation, Friedel-Crafts, coupling reactions), impurity profiling, 200+ validated analytical methods, and an integrated R&D-to-commercial scale-up pipeline anchored by a three-pillar basic/applied/experimental research framework. Quality assurance is supported by HPLC, GC, UV, FTIR, and stability-chamber instrumentation.

Reine Lifescience operates a direct B2B enterprise sales model with quote-based pricing, regional sales teams split between Pan India and International, and lead generation conducted primarily through CPHI pharmaceutical trade exhibitions in Thailand, Korea, Frankfurt, India, and China. The company is founder/management-controlled under Managing Director Kalpesh Kothiya and directors Amish Shah and Devang Shah, with no disclosed institutional investor or parent company and no publicly reported revenue or funding data.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersAnkleshwar, India
HQ citystring
Ankleshwar
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
active pharmaceutical ingredients, API manufacturing, contract development manufacturing, pharmaceutical intermediates, CDMO services
Industry5 codes
PRIMARYHLAGAHAA
Small-Molecule API Process Development & Route Scouting
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAG
Impurity / Reference Standard Synthesis & Characterization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAL
GMP Scale-Up, Tech Transfer & Process Validation (PPQ)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAKAL
Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
NAICS code2 codes
  • Pharmaceutical and Medicine Manufacturing3254
  • Scientific Research and Development Services5417
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Services-Commercial Physical & Biological Research8731
Product category
Active Pharmaceutical Ingredients (APIs)
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1API Manufacturing and Sales
TypeOne Time License
Description

Manufacturing and selling Active Pharmaceutical Ingredients (APIs) to pharmaceutical companies worldwide. Revenue generated through direct B2B sales of pharmaceutical-grade APIs meeting global regulatory standards including WHO-GMP, CEP, and pharmacopeial requirements (IP, BP, EP, USP).

reinelifescience.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Reine Lifescience manufactures and sells Active Pharmaceutical Ingredients (APIs) and advanced pharmaceutical intermediates from its cGMP-compliant facilities in Ankleshwar, Gujarat, India. The company offers a portfolio of 27 commercialized APIs and 5 under development spanning therapeutic categories including cardiovascular, anti-hypertensive, anti-diabetic, anticoagulant, and anti-epilepsy medications. It also provides integrated CDMO (Contract Development & Manufacturing Organization) services, R&D services (organic synthesis, impurity profiling, analytical method validation), and quality assurance/control to pharmaceutical companies in regulated markets worldwide.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 50+ API products manufactured with regulatory compliance
+3 more records
Product overview1 text field

Reine Lifescience offers a unified portfolio centered on Active Pharmaceutical Ingredients (APIs) manufacturing, complemented by integrated CDMO services. The core offering consists of 27+ commercialized APIs and 5 products under development, spanning therapeutic categories including cardiovascular, anti-hypertensive, anti-diabetic, anticoagulant, and anti-epilepsy medications. These are supported by research and development services (organic synthesis, impurity profiling, analytical method validation), quality assurance and control systems, and cGMP-compliant manufacturing capabilities. The company operates as both an API manufacturer and a full-service CDMO partner, providing end-to-end solutions from molecule development through commercial-scale production.

Product and service5 records
1Active Pharmaceutical Ingredients (APIs)
CategoryCore product
Description

High-purity pharmaceutical APIs manufactured in WHO-GMP and CEP certified facilities, serving regulated markets worldwide to IP, BP, EP, and USP pharmacopeial standards. Portfolio includes products such as Amiodarone HCL, Apixaban, Atorvastatin Calcium, Metoprolol Succinate, Pregabalin, Rosuvastatin Calcium, and Sitagliptin Phosphate Monohydrate, among others.

2CDMO Services
CategoryService
Description

End-to-end Contract Development & Manufacturing Organization services providing process development, analytical development, manufacturing, and regulatory support from early development through commercial scale production. Targeted at pharmaceutical companies seeking regulatory-compliant contract manufacturing partners.

3Research & Development
CategoryService
Description

Innovation-driven research and development services focused on developing cost-effective and scalable processes for pharmaceutical intermediates and APIs, including organic synthesis, impurity profiling, and analytical method validation aligned with ICH guidelines.

4Quality Assurance & Quality Control
CategoryService
Description

Integrated QA/QC systems ensuring every API consistently meets stringent global cGMP standards, with advanced analytical laboratories (HPLC, GC, UV spectrophotometers, FTIR, stability chambers) and comprehensive documentation control.

5Manufacturing
CategoryService
Description

cGMP-compliant manufacturing facilities with 200+ KL reactor capacity and 2000+ MT/year production capability, featuring dedicated cleanroom facilities and integrated R&D, QC, and QA laboratories located in Ankleshwar, Gujarat, India.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Indian API and finished-formulation manufacturer with focus on high-volume small-molecule categories. Comparable to Reine on API manufacturing scale, regulatory certification profile, and customer segment.

TypeDirect peer
Description

India-based small-molecule API manufacturer and CDMO serving global pharma with WHO-GMP, USFDA, and EDQM approvals. Closely comparable to Reine in scale, therapeutic category focus, and CDMO+R&D service profile.

TypeDirect peer
Description

Indian specialty chemicals and CDMO business of Jubilant with API and intermediates manufacturing for global pharma. Comparable to Reine in small-molecule API, custom synthesis, and life science chemistry services.

TypeDirect peer
Description

Global CDMO business of Piramal Pharma providing API manufacturing and drug development services with multiple regulatory inspections. Operates in the same end-to-end small-molecule CDMO space as Reine.

TypeDirect peer
Description

Indian pharma company focused on API manufacturing, CDMO services, and specialty intermediates with regulated-market approvals. Direct peer given shared NCE API/CDMO and contract manufacturing profile.

TypeBroad incumbent
Description

Indian animal health and API manufacturer with operations in regulated markets. A broader incumbent peer given its API manufacturing infrastructure and global regulatory footprint.

TypeDirect peer
Description

Indian CDMO offering contract research, process development, and small-molecule API manufacturing with regulatory compliance. Directly comparable to Reine's CDMO and R&D service layer targeting innovator and generic pharma.

TypeDirect peer
Description

Leading Indian API manufacturer and CDMO with deep small-molecule generics and custom synthesis capabilities across regulated markets. Directly comparable to Reine's API manufacturing and CDMO service offering at significantly larger scale.

TypeDirect peer
Description

Indian API and CDMO player with a diversified small-molecule portfolio spanning anti-retrovirals, cardiovascular, and other therapeutic categories. Comparable to Reine in API manufacturing focus, regulatory certifications, and CDMO services.

TypeBroad incumbent
Description

Large Indian pharmaceutical company with vertically integrated API and finished-dosage operations across cardiovascular, anti-diabetic, and other categories. Reine's overlap on the API side makes it a relevant broader incumbent reference.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Reine Lifescience

Active Pharmaceutical Ingredients (APIs)reinelifescience.com

What Reine Lifescience does

Reine Lifescience is a privately held Indian active pharmaceutical ingredient (API) manufacturer headquartered in Ankleshwar, Gujarat, that also operates as a contract development and manufacturing organization (CDMO) for global pharmaceutical clients. Founded in 1993 as Reine Chemicals Pvt. Ltd. and rebranded in 2014-2015 to reflect its pivot into regulated pharmaceutical APIs, the company runs cGMP-compliant manufacturing facilities spanning more than 20,000 square meters with 200+ KL of reactor capacity and approximately 2,000 MT/year of API production output. Its commercial portfolio covers roughly 27-29 APIs across therapeutic categories such as cardiovascular, anti-hypertensive, anti-diabetic, anti-epilepsy, anticoagulant, neuropathic pain, anti-allergic, anti-asthmatic, and iron chelation, manufactured to IP, BP, EP, and USP pharmacopeial standards, with five additional APIs in development.

The company holds a layered regulatory stack — WHO-GMP, CEP/EDQM, MFDS Korea, ANVISA (post-2026 inspection), and ISO 9001/14001/45001 — and exports to 45+ countries across South Asia, Asia Pacific, Europe, and global markets. Its technical capabilities rest on advanced organic synthesis (cyclization, condensations, hydrogenation, Friedel-Crafts, coupling reactions), impurity profiling, 200+ validated analytical methods, and an integrated R&D-to-commercial scale-up pipeline anchored by a three-pillar basic/applied/experimental research framework. Quality assurance is supported by HPLC, GC, UV, FTIR, and stability-chamber instrumentation.

Reine Lifescience operates a direct B2B enterprise sales model with quote-based pricing, regional sales teams split between Pan India and International, and lead generation conducted primarily through CPHI pharmaceutical trade exhibitions in Thailand, Korea, Frankfurt, India, and China. The company is founder/management-controlled under Managing Director Kalpesh Kothiya and directors Amish Shah and Devang Shah, with no disclosed institutional investor or parent company and no publicly reported revenue or funding data.

Reine Lifescience firmographics

Firmographics
Name
Reine Lifescience
Legal name
Reine Lifescience
Website
https://reinelifescience.com
Company type
Private
Founded year
1993
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

Reine Lifescience industry classification

Industry
Product category
Active Pharmaceutical Ingredients (APIs)
NAICS
Pharmaceutical and Medicine Manufacturing (3254), Scientific Research and Development Services (5417)
SIC
Medicinal Chemicals & Botanical Products (2833), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAHAA
Small-Molecule API Process Development & Route Scouting
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAG
Impurity / Reference Standard Synthesis & Characterization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAL
GMP Scale-Up, Tech Transfer & Process Validation (PPQ)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAKAL
Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Active pharmaceutical ingredients
  • API manufacturing
  • Contract development manufacturing
  • Pharmaceutical intermediates
  • CDMO services

Where Reine Lifescience is headquartered

Location

Headquarters

HQ city
Ankleshwar
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Reine Lifescience business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. API Manufacturing and Sales: Manufacturing and selling Active Pharmaceutical Ingredients (APIs) to pharmaceutical companies worldwide. Revenue generated through direct B2B sales of pharmaceutical-grade APIs meeting global regulatory standards including WHO-GMP, CEP, and pharmacopeial requirements (IP, BP, EP, USP).

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Reine Lifescience product offering

Product offering

Core offering

Reine Lifescience manufactures and sells Active Pharmaceutical Ingredients (APIs) and advanced pharmaceutical intermediates from its cGMP-compliant facilities in Ankleshwar, Gujarat, India. The company offers a portfolio of 27 commercialized APIs and 5 under development spanning therapeutic categories including cardiovascular, anti-hypertensive, anti-diabetic, anticoagulant, and anti-epilepsy medications. It also provides integrated CDMO (Contract Development & Manufacturing Organization) services, R&D services (organic synthesis, impurity profiling, analytical method validation), and quality assurance/control to pharmaceutical companies in regulated markets worldwide.

Product overview

Reine Lifescience offers a unified portfolio centered on Active Pharmaceutical Ingredients (APIs) manufacturing, complemented by integrated CDMO services. The core offering consists of 27+ commercialized APIs and 5 products under development, spanning therapeutic categories including cardiovascular, anti-hypertensive, anti-diabetic, anticoagulant, and anti-epilepsy medications. These are supported by research and development services (organic synthesis, impurity profiling, analytical method validation), quality assurance and control systems, and cGMP-compliant manufacturing capabilities. The company operates as both an API manufacturer and a full-service CDMO partner, providing end-to-end solutions from molecule development through commercial-scale production.

Differentiator

Problem solved

Functional benefit

Products and services

  • Active Pharmaceutical Ingredients (APIs) High-purity pharmaceutical APIs manufactured in WHO-GMP and CEP certified facilities, serving regulated markets worldwide to IP, BP, EP, and USP pharmacopeial standards. Portfolio includes products such as Amiodarone HCL, Apixaban, Atorvastatin Calcium, Metoprolol Succinate, Pregabalin, Rosuvastatin Calcium, and Sitagliptin Phosphate Monohydrate, among others.
  • CDMO Services End-to-end Contract Development & Manufacturing Organization services providing process development, analytical development, manufacturing, and regulatory support from early development through commercial scale production. Targeted at pharmaceutical companies seeking regulatory-compliant contract manufacturing partners.
  • Research & Development Innovation-driven research and development services focused on developing cost-effective and scalable processes for pharmaceutical intermediates and APIs, including organic synthesis, impurity profiling, and analytical method validation aligned with ICH guidelines.
  • Quality Assurance & Quality Control Integrated QA/QC systems ensuring every API consistently meets stringent global cGMP standards, with advanced analytical laboratories (HPLC, GC, UV spectrophotometers, FTIR, stability chambers) and comprehensive documentation control.
  • Manufacturing cGMP-compliant manufacturing facilities with 200+ KL reactor capacity and 2000+ MT/year production capability, featuring dedicated cleanroom facilities and integrated R&D, QC, and QA laboratories located in Ankleshwar, Gujarat, India.

Quantifiable outcome

  • 50+ API products manufactured with regulatory compliance
  • +3 more outcomes

Companies that use Reine Lifescience

Customer profile

Segments1 record

Ideal customer profiles1 record

Reine Lifescience technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Reine Lifescience partnerships and signals

Strategic signal

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

Reine Lifescience competitors and assessment

Company assessment

Direct peers

  • Granules India: Indian API and finished-formulation manufacturer with focus on high-volume small-molecule categories. Comparable to Reine on API manufacturing scale, regulatory certification profile, and customer segment.
  • Neuland Laboratories: India-based small-molecule API manufacturer and CDMO serving global pharma with WHO-GMP, USFDA, and EDQM approvals. Closely comparable to Reine in scale, therapeutic category focus, and CDMO+R&D service profile.
  • Jubilant Ingrevia: Indian specialty chemicals and CDMO business of Jubilant with API and intermediates manufacturing for global pharma. Comparable to Reine in small-molecule API, custom synthesis, and life science chemistry services.
  • Piramal Pharma Solutions: Global CDMO business of Piramal Pharma providing API manufacturing and drug development services with multiple regulatory inspections. Operates in the same end-to-end small-molecule CDMO space as Reine.
  • Suven Life Sciences (now Suven Pharmaceuticals): Indian pharma company focused on API manufacturing, CDMO services, and specialty intermediates with regulated-market approvals. Direct peer given shared NCE API/CDMO and contract manufacturing profile.
  • Sai Life Sciences: Indian CDMO offering contract research, process development, and small-molecule API manufacturing with regulatory compliance. Directly comparable to Reine's CDMO and R&D service layer targeting innovator and generic pharma.
  • Divis Laboratories: Leading Indian API manufacturer and CDMO with deep small-molecule generics and custom synthesis capabilities across regulated markets. Directly comparable to Reine's API manufacturing and CDMO service offering at significantly larger scale.
  • Laurus Labs: Indian API and CDMO player with a diversified small-molecule portfolio spanning anti-retrovirals, cardiovascular, and other therapeutic categories. Comparable to Reine in API manufacturing focus, regulatory certifications, and CDMO services.

Broad incumbents

  • Sequent Scientific: Indian animal health and API manufacturer with operations in regulated markets. A broader incumbent peer given its API manufacturing infrastructure and global regulatory footprint.
  • Aurobindo Pharma: Large Indian pharmaceutical company with vertically integrated API and finished-dosage operations across cardiovascular, anti-diabetic, and other categories. Reine's overlap on the API side makes it a relevant broader incumbent reference.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Reine Lifescience social profiles

Digital presence

Reine Lifescience compliance and trust

Trust signal

Compliance8 records

Reine Lifescience financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Reine Lifescience leadership team

Management profile

Number of profiles

Profiles3 records

Reine Lifescience funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Reine Lifescience M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Reine Lifescience

What does Reine Lifescience do?

Reine Lifescience manufactures and sells Active Pharmaceutical Ingredients (APIs) and advanced pharmaceutical intermediates from its cGMP-compliant facilities in Ankleshwar, Gujarat, India. The company offers a portfolio of 27 commercialized APIs and 5 under development spanning therapeutic categories including cardiovascular, anti-hypertensive, anti-diabetic, anticoagulant, and anti-epilepsy medications. It also provides integrated CDMO (Contract Development & Manufacturing Organization) services, R&D services (organic synthesis, impurity profiling, analytical method validation), and quality assurance/control to pharmaceutical companies in regulated markets worldwide.

Is Reine Lifescience a public or private company?

Reine Lifescience is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Reine Lifescience founded?

Reine Lifescience was founded in 1993. It employs 51 to 100 people.

Where is Reine Lifescience based?

Reine Lifescience is headquartered in Ankleshwar, India, in the Asia region.

How does Reine Lifescience make money?

One revenue line is on record: API Manufacturing and Sales.

Who are Reine Lifescience's main competitors?

Direct peers on record are Granules India, Neuland Laboratories, Jubilant Ingrevia, Piramal Pharma Solutions, Suven Life Sciences (now Suven Pharmaceuticals), Sai Life Sciences, Divis Laboratories and Laurus Labs. Broad incumbents are Sequent Scientific and Aurobindo Pharma.

Does Reine Lifescience have an API?

No public API is recorded for Reine Lifescience.

What industry is Reine Lifescience in?

Reine Lifescience's product category is Active Pharmaceutical Ingredients (APIs). Its primary akta.pro industry code is HLAGAHAA, Small-Molecule API Process Development & Route Scouting, with a secondary code of HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC). Its NAICS code is 3254 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales